Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric T Clambey

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Cancer Letters|January 19, 2023
Novel EGFR-mutant mouse models of lung adenocarcinoma reveal adaptive immunity requirement for durable osimertinib responseEmily K Kleczko, Anh T Le, Trista K Hinz, et al.
The Journal of Clinical Investigation|November 10, 2015
Aging-associated inflammation promotes selection for adaptive oncogenic events in B cell progenitorsCurtis J Henry, Matias Casás-Selves, Jihye Kim, et al.
Immunohorizons|February 20, 2020
High-Dimensional Analysis of Postsplenectomy Peripheral Immune Cell ChangesJessica S W Borgers, Richard P Tobin, Victoria M Vorwald, et al.
Cancer Research|March 22, 2019
Inhibition of EphB4-Ephrin-B2 Signaling Reprograms the Tumor Immune Microenvironment in Head and Neck CancersShilpa Bhatia, Ayman Oweida, Shelby Lennon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 18, 2020
Cancer Cell-Intrinsic Expression of MHC Class II Regulates the Immune Microenvironment and Response to Anti-PD-1 Therapy in Lung AdenocarcinomaAmber M Johnson, Bonnie L Bullock, Alexander J Neuwelt, et al.
JCI Insight|June 22, 2023
Immune checkpoint activity regulates polycystic kidney disease progressionEmily K Kleczko, Dustin T Nguyen, Kenneth H Marsh, et al.
Journal for Immunotherapy of Cancer|April 22, 2020
Cancer cell-intrinsic expression of MHC II in lung cancer cell lines is actively restricted by MEK/ERK signaling and epigenetic mechanismsAlexander J Neuwelt, Abigail K Kimball, Amber M Johnson, et al.
Kidney International|September 26, 2018
CD8<sup>+</sup> T cells modulate autosomal dominant polycystic kidney disease progressionEmily K Kleczko, Kenneth H Marsh, Logan C Tyler, et al.
Life Science Alliance|May 29, 2019
Tumor-intrinsic response to IFNγ shapes the tumor microenvironment and anti-PD-1 response in NSCLCBonnie L Bullock, Abigail K Kimball, Joanna M Poczobutt, et al.
Science Advances|December 13, 2024
Regulation of volume-regulated anion channels alters sensitivity to platinum chemotherapyLily Elizabeth R Feldman, Saswat Mohapatra, Robert T Jones, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Cancer Letters|January 19, 2023
Novel EGFR-mutant mouse models of lung adenocarcinoma reveal adaptive immunity requirement for durable osimertinib responseEmily K Kleczko, Anh T Le, Trista K Hinz, et al.
The Journal of Clinical Investigation|November 10, 2015
Aging-associated inflammation promotes selection for adaptive oncogenic events in B cell progenitorsCurtis J Henry, Matias Casás-Selves, Jihye Kim, et al.
Immunohorizons|February 20, 2020
High-Dimensional Analysis of Postsplenectomy Peripheral Immune Cell ChangesJessica S W Borgers, Richard P Tobin, Victoria M Vorwald, et al.
Cancer Research|March 22, 2019
Inhibition of EphB4-Ephrin-B2 Signaling Reprograms the Tumor Immune Microenvironment in Head and Neck CancersShilpa Bhatia, Ayman Oweida, Shelby Lennon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 18, 2020
Cancer Cell-Intrinsic Expression of MHC Class II Regulates the Immune Microenvironment and Response to Anti-PD-1 Therapy in Lung AdenocarcinomaAmber M Johnson, Bonnie L Bullock, Alexander J Neuwelt, et al.
JCI Insight|June 22, 2023
Immune checkpoint activity regulates polycystic kidney disease progressionEmily K Kleczko, Dustin T Nguyen, Kenneth H Marsh, et al.
Journal for Immunotherapy of Cancer|April 22, 2020
Cancer cell-intrinsic expression of MHC II in lung cancer cell lines is actively restricted by MEK/ERK signaling and epigenetic mechanismsAlexander J Neuwelt, Abigail K Kimball, Amber M Johnson, et al.
Kidney International|September 26, 2018
CD8<sup>+</sup> T cells modulate autosomal dominant polycystic kidney disease progressionEmily K Kleczko, Kenneth H Marsh, Logan C Tyler, et al.
Life Science Alliance|May 29, 2019
Tumor-intrinsic response to IFNγ shapes the tumor microenvironment and anti-PD-1 response in NSCLCBonnie L Bullock, Abigail K Kimball, Joanna M Poczobutt, et al.
Science Advances|December 13, 2024
Regulation of volume-regulated anion channels alters sensitivity to platinum chemotherapyLily Elizabeth R Feldman, Saswat Mohapatra, Robert T Jones, et al.
Pageof 6